HOME >> BIOLOGY >> NEWS
Newcastle scientists get UK's first stem cell license

is being done on our site."

In principle (ES) cells can be used to make any cell type in the body and so replace cells that have been lost as a result of disease or injury.

The procedure involves reprogramming cells from, say skin tissue of a patient who has lost important cells through disease. The re-programmed cells will re- grow as the cells needed by that patient.

The approved research requires the nucleus from a skin cell to be removed and placed into an unfertilized egg. This egg is then stimulated to divide until a group of cells form. Stem cells are then isolated from this group and have the potential to grow into any cell type in the body. They could be directed to grow into, say, liver cells to cure liver disease, nerve cells to allow patients with spinal injury to walk again or nerve cells to overcome the misery of Alzheimer's disease.

Professor Trevor Page, Pro-Vice-Chancellor for external relations and research at Newcastle University, said: "Stem cell research is one of the most exciting and promising areas of biomedicine, offering the potential of therapies for diseases such as Parkinson's, liver disease, heart disease and dementia. Our success in this field of research demonstrates the highly productive nature of the partnership between Newcastle University's Institute of Human Genetics, the NHS and the Center for Life, not only in the form of cutting-edge research but also in promoting public debate on the ethical issues arising from such work.

Dr. Simon Woods, bioethicist at Newcastle's Policy, Ethics and Life Sciences Research Institutesaid: "The granting of this license is a major event, and a reflection of the excellence of the research being carried out at Newcastle University. At PEALS we will continue to stimulate public debate and explore with the researchers the ethical and social questions which arise alongs
'"/>

Contact: Makeda Scott
makeda.scott@fco.gov.uk
202-588-6523
British Information Services
11-Aug-2004


Page: 1 2 3 4

Related biology news :

1. Therapeutic cloning may be permitted at Newcastle University
2. Exotic Newcastle disease
3. DNA lends scientists a hand, revealing new chemical reactions
4. Conference at UH opens doors for new scientists, engineers
5. Wisconsin scientists develop quick botox test
6. UCI scientists successfully target key HIV protein; breakthrough may lead to new drug therapies
7. Alaska scientists find Arctic tundra yields surprising carbon loss
8. UAF scientists discover new marine habitat in Alaska
9. Information system to help scientists analyze mechanisms of social behavior
10. Zoonotic diseases - European scientists unite to fight diseases
11. Israeli scientists reveal the plan of a key cellular machine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/4/2019)... ... 02, 2019 , ... Stay on top of current hot topics through free ... to all webinars is free, so be sure to register today to save your ... http://www.xtalks.com to see our upcoming webinars: , CLINICAL OPERATIONS , August 27 – ...
(Date:8/1/2019)... ... July 31, 2019 , ... Molecular ... launch of the next generation of its FLIPR® Penta High-Throughput Cellular Screening System. ... FLIPR® platform for monitoring of G-protein-coupled receptors (GPCRs) and ion channels, offering a ...
(Date:7/24/2019)... ... July 24, 2019 , ... NDA Partners Chairman Carl ... with more than 20 years of experience working in scientific research and FDA-regulated ... as an Expert Consultant. , Dr. Hartzfeld has experience in all aspects of ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... June 10, 2019 , ... ... add 80 of its scientific journals to DeepDyve’s rental service for peer-reviewed journals. ... continually expanding library of more than 20 million articles, sourced from more than ...
(Date:6/11/2019)... DURHAM, N.C. (PRWEB) , ... June 11, 2019 ... ... how extracellular vesicles derived from human mesenchymal stem cells (MSC-EV) are able to ... and cloning ability. In a test on mice, MSC-EVs also increased the cells’ ...
(Date:5/31/2019)... ... May 29, 2019 , ... ... from the USPTO providing proprietary interest to our methodology, processes, and diagnostic ... DIAGNOSIS AND TREATMENT… extends Somnology’s IP rights including our proprietary sleep scoring ...
(Date:5/31/2019)... ... May 30, 2019 , ... A study released today ... system for the sustained release of human placental stem cell (HPSC)-derived conditioned medium ... to deliver CM into the injured kidney, where it helped restore function and ...
Breaking Biology Technology:
Cached News: